Tag: Tevogen Bio Oncology revenue forecast analysis
Tevogen Bio Oncology Forecasts $1B in Launch Year Revenue, $10-14B in 5 Years; Expansion...
Tevogen Bio, a biotech company focused on developing immunotherapy treatments for infectious diseases and cancers, has made a bold prediction regarding its oncology pipeline....